Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q6D7Z5

Entry ID Method Resolution Chain Position Source
AF-Q6D7Z5-F1 Predicted AlphaFoldDB

No variants for Q6D7Z5

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q6D7Z5

No associated diseases with Q6D7Z5

2 regional properties for Q6D7Z5

Type Name Position InterPro Accession
domain Adenylate kinase, active site lid domain 123 - 158 IPR007862
conserved_site Adenylate kinase, conserved site 81 - 92 IPR033690

Functions

Description
EC Number 2.7.4.3 Phosphotransferases with a phosphate group as acceptor
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

2 GO annotations of molecular function

Name Definition
adenylate kinase activity Catalysis of the reaction: ATP + AMP = 2 ADP.
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.

2 GO annotations of biological process

Name Definition
AMP salvage The chemical reactions and pathways resulting in the formation of adenosine monophosphate (AMP) from derivatives of it (either adenine, ADP or adenosine 3',5'-bisphosphate) without de novo synthesis.
phosphorylation The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MRIILLGAPG AGKGTQAQFI MGKYGIPQIS TGDMLRAAVK AGTELGKQAK EIMDAGKLVT
70 80 90 100 110 120
DELVIALVKE RIAQDDCRNG FLLDGFPRTI PQADAMKDAG IDVDYVIEFA VPDELIIDRI
130 140 150 160 170 180
IGRRVHAASG RVYHVKFNPP KVEDKDDVTG EDLSVRKDDQ EDTVRKRLVE YHQQTAPLVS
190 200 210
YYQKEADAGN TRYFKVEGTR KVEEVRAELE TILG